Page 21 - Lxrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lxrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lxrx Today - Breaking & Trending Today
Xerox (NYSE:XRX – Get Rating) will release its earnings data on Wednesday, April 19th. Xerox has set its FY 2023 guidance at EPS. Xerox (NYSE:XRX – Get Rating) last released its earnings results on Thursday, January 26th. The information technology services provider reported $0.89 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by […] ....
StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a report released on Saturday morning. Separately, Jefferies Financial Group initiated coverage on shares of Lexicon Pharmaceuticals in a report on Tuesday, March 7th. They issued a hold rating and a $3.00 price objective for the company. Lexicon Pharmaceuticals Trading […] ....
StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a research note released on Saturday. Separately, Jefferies Financial Group initiated coverage on Lexicon Pharmaceuticals in a report on Tuesday, March 7th. They set a hold rating and a $3.00 target price on the stock. Lexicon Pharmaceuticals Trading Down 0.4 […] ....
Pinnacle Associates Ltd. cut its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) by 2.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,983,522 shares of the biopharmaceutical company’s stock after selling 47,685 shares during the quarter. Pinnacle Associates Ltd. owned […] ....
Xerox Holdings Co. (NYSE:XRX – Get Rating) has earned a consensus rating of “Reduce” from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a sell recommendation and one has given a buy recommendation to the company. The average 12 month price target among […] ....